Treatment of tuberculosis in HIV-infected patients:: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin

被引：25
|
作者：
Moreno, S [1 ]
Podzamczer, D
Blázquez, R
Iribarren, JA
Ferrer, E
Reparaz, J
Peña, JM
Cabrero, E
Usán, L
机构：
[1] Hosp Ramon & Cajal, Dept Infect Dis, E-28034 Madrid, Spain
[2] Bellvitge Hosp, Dept Infect Dis, Barcelona, Spain
[3] Hosp Morales Meseguer, Dept Microbiol & Infect Dis, Murcia, Spain
[4] Hosp NS Aranzazu, Dept Infect Dis, San Sebastian, Spain
[5] Hosp Navarra, Dept Infect Dis, Pamplona, Spain
[6] Hosp La Paz, AIDS Unit, Madrid, Spain
[7] Abbott Labs, Dept Med, Madrid, Spain
来源：
AIDS | 2001年 / 15卷 / 09期
关键词：
D O I：
10.1097/00002030-200106150-00018
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1185 / 1187
页数：3
相关论文
共 50 条
  • [21] Reply: Treatment of tuberculosis in HIV-infected patients
    Pozniak, AL
    Ormerod, LP
    Miller, R
    AIDS, 1999, 13 (11) : 1431 - 1432
  • [22] Acute hepatitis in HIV-infected patients during ritonavir treatment
    Arribas, JR
    Ibáñez, C
    Ruiz-Antoran, B
    Peña, JM
    Esteban-Calvo, C
    Frías, J
    Vázquez, JJ
    González-García, JJ
    AIDS, 1998, 12 (13) : 1722 - 1724
  • [23] Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients
    López-Suárez, A
    del Alamo, CFG
    Pérez-Guzmán, E
    Girón-González, JA
    AIDS, 1998, 12 (06) : 685 - 686
  • [24] Efficacy of Lopinavir-Ritonavir Reduced Dose in HIV-Infected Patients
    Lattuada, Emanuela
    Lanzafame, Massimiliano
    Vento, Sandro
    AIDS PATIENT CARE AND STDS, 2011, 25 (08) : 455 - 456
  • [25] Cardiovascular risk of HIV-infected patients on antiretroviral treatment
    Espino-Paisan, E.
    Rojo-Valdes, J.
    Lamas, M. J.
    Esteban-Cartelle, H.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 920 - 921
  • [26] Therapeutic drug monitoring of isoniazid, rifampin, and pyrazinamide in HIV-infected patients with tuberculosis
    Baniasadi, Shadi
    Fahimi, Fanak
    Tabarsi, Payam
    Nadji, Seyed Alireza
    Khabiri, Shadi
    Shahsavari, Nahid
    Kobarfard, Farzad
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [27] Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patients
    Ramautarsing, Reshmie A.
    van der Lugt, Jasper
    Gorowara, Meena
    Sophonphan, Jiratchaya
    Ananworanich, Jintanat
    Lange, Joep M. A.
    Burger, David M.
    Phanuphak, Praphan
    Ruxthungtham, Kiat
    Avihingsanon, Anchalee
    ANTIVIRAL THERAPY, 2013, 18 (02) : 249 - 252
  • [28] Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa
    Ciaffi, Laura
    Koulla-Shiro, Sinata
    Sawadogo, Adrien
    le Moing, Vincent
    Eymard-Duvernay, Sabrina
    Izard, Susanne
    Kouanfack, Charles
    Gueye, Ndeye Fatou Ngom
    Fobang, Avelin Aghokeng
    Reynes, Jacques
    Calmy, Alexandra
    Delaporte, Eric
    AIDS, 2015, 29 (12) : 1473 - 1481
  • [29] Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children
    Rudin, Christoph
    Burri, Marcus
    Shen, Yang
    Rode, Richard
    Nadal, David
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (05) : 431 - 437
  • [30] Undiagnosed Active Tuberculosis in HIV-Infected Patients Commencing Antiretroviral Therapy
    Meintjes, Graeme
    Wilkinson, Robert J.
    CLINICAL INFECTIOUS DISEASES, 2010, 51 (07) : 830 - 832
12345